New Academy Research Fellowships, Clinical Researchers, and Academy Projects in the fields of biosciences, health, and environmental research

The Research Council of Finland’s Scientific Council for Biosciences, Health and the Environment has granted funding for new Academy Research Fellowships, Clinical Researchers, and Academy Projects.

Funding is granted for a period of four years.

Researchers at the University of Oulu who received funding

Academy Research Fellowship funding is intended for young researchers who have rapidly advanced in their careers, are internationally networked, and conduct high-quality, impactful, and innovative scientific research.

Inês Paciência: Interdependence between climate change, biodiversity and respiratory health from pregnancy to adulthood, € 681,437

Tuija Maliniemi: Unexplored long-term patterns and drivers of biodiversity change, € 613,363

The purpose of Clinical Researcher funding is to support high-level scientific research while enabling physicians and other researchers engaged in clinical patient care to conduct part-time research alongside their clinical duties. This funding instrument is particularly significant for the career development of young clinical researchers.

Elisa Rahikkala: Advancing Personalized Medicine for Rare Diseases: Genetic Insights from the Finnish population isolate, €239,922

Funded projects at the University of Oulu

The aim of Academy Project funding is to promote the renewal and diversity of Finnish science, improve research quality, and increase scientific and broader societal impact. The goal is to support internationally high-level research, potential scientific breakthroughs, and collaboration with the best international research groups.

Reetta Hinttala: Defects of centriolar HYLS1 protein: in vivo outcomes in development and disease, € 600,000

Rajaram Venkatesan: Molecular mechanisms of lipid import in mycobacteria, € 599,898

Johanna Uusimaa: Drug-resistant childhood-onset epilepsies and disease models for novel drug target discovery (DIAMOND), € 499,390

Risto Kerkelä: Novel molecular mechanism for disrupting TGFß1 signaling and development of myocardial fibrosis, € 598,234

Tejesvi Mysore Vishakante Gowda: Early-life microbiota-derived Extra cellular vesicles (EVOLVE), € 349,976

Read more in the press release from the Research Council of Finland.

Last updated: 17.6.2025